메뉴 건너뛰기




Volumn 35, Issue 9, 2014, Pages 442-449

Siderophore-drug complexes: Potential medicinal applications of the 'Trojan horse' strategy

Author keywords

iron overload; magnetic drug carriers; siderophore; Trojan horse strategy

Indexed keywords

ABC TRANSPORTER; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBOXYMYCOBACTIN; DEFEROXAMINE; FERRIMYCIN; GRISEIN; IRON; MEMBRANE RECEPTOR; PERIPLASMIC BINDING PROTEIN; SIDEROMYCIN; SIDEROPHORE; SIDEROPHORE ANTIBIOTIC CONJUGATE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

EID: 84905299821     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.06.007     Document Type: Review
Times cited : (133)

References (65)
  • 1
    • 67651247638 scopus 로고    scopus 로고
    • Siderophores as drug delivery agents: Application of the 'Trojan Horse' strategy
    • U. Möllmann et al. Siderophores as drug delivery agents: application of the 'Trojan Horse' strategy Biometals 22 2009 615 624
    • (2009) Biometals , vol.22 , pp. 615-624
    • Möllmann, U.1
  • 2
    • 67651247598 scopus 로고    scopus 로고
    • Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin 'Trojan Horse' antibiotics and synthetic desferridanoxamine-antibiotic conjugates
    • T.A. Wencewicz et al. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin 'Trojan Horse' antibiotics and synthetic desferridanoxamine-antibiotic conjugates Biometals 22 2009 633 648
    • (2009) Biometals , vol.22 , pp. 633-648
    • Wencewicz, T.A.1
  • 3
    • 59449105814 scopus 로고    scopus 로고
    • Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents
    • M.J. Miller et al. Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents Biometals 22 2009 61 75
    • (2009) Biometals , vol.22 , pp. 61-75
    • Miller, M.J.1
  • 4
    • 0027945605 scopus 로고
    • Microbial iron transport
    • M.L. Guerinot Microbial iron transport Ann. Rev. Microbiol. 48 1994 743 772
    • (1994) Ann. Rev. Microbiol. , vol.48 , pp. 743-772
    • Guerinot, M.L.1
  • 5
    • 0038579427 scopus 로고    scopus 로고
    • Bacterial iron homeostasis
    • S.C. Andrews et al. Bacterial iron homeostasis FEMS Microbiol. Rev. 27 2003 215 237
    • (2003) FEMS Microbiol. Rev. , vol.27 , pp. 215-237
    • Andrews, S.C.1
  • 6
    • 77951981537 scopus 로고    scopus 로고
    • Chemistry and biology of siderophores
    • R.C. Hider, and X. Kong Chemistry and biology of siderophores Nat. Prod. Rep. 27 2010 637 657
    • (2010) Nat. Prod. Rep. , vol.27 , pp. 637-657
    • Hider, R.C.1    Kong, X.2
  • 7
    • 0028850367 scopus 로고
    • Siderophores: Structure and function of microbial iron transport compounds
    • J.B. Neilands Siderophores: structure and function of microbial iron transport compounds J. Biol. Chem. 270 1995 26723 26726
    • (1995) J. Biol. Chem. , vol.270 , pp. 26723-26726
    • Neilands, J.B.1
  • 8
    • 50049089034 scopus 로고    scopus 로고
    • Structural biology of bacterial iron uptake
    • K.D. Krewulak, and H.J. Vogel Structural biology of bacterial iron uptake Biochim. Biophys. Acta 2008 1781 1804
    • (2008) Biochim. Biophys. Acta , pp. 1781-1804
    • Krewulak, K.D.1    Vogel, H.J.2
  • 9
    • 34548739613 scopus 로고    scopus 로고
    • Siderophore-based iron acquisition and pathogen control
    • M. Miethke, and M.A. Marahiel Siderophore-based iron acquisition and pathogen control Microbiol. Mol. Biol. Rev. 71 2007 3413 3451
    • (2007) Microbiol. Mol. Biol. Rev. , vol.71 , pp. 3413-3451
    • Miethke, M.1    Marahiel, M.A.2
  • 10
    • 21844449490 scopus 로고    scopus 로고
    • Siderophore-mediated chemistry and microbial uptake of plutonium
    • M.P. Neu Siderophore-mediated chemistry and microbial uptake of plutonium Los Alamos Sci. 26 2000 416 417
    • (2000) Los Alamos Sci. , vol.26 , pp. 416-417
    • Neu, M.P.1
  • 11
    • 33847147545 scopus 로고    scopus 로고
    • Complexation of Pu(IV) with the natural siderophore desferrioxamine B and the redox properties of Pu(IV) siderophore complexes
    • H. Boukhalfa et al. Complexation of Pu(IV) with the natural siderophore desferrioxamine B and the redox properties of Pu(IV) siderophore complexes Inorg. Chem. 46 2007 1018 1026
    • (2007) Inorg. Chem. , vol.46 , pp. 1018-1026
    • Boukhalfa, H.1
  • 12
    • 35348830385 scopus 로고    scopus 로고
    • Iron chelation equilibria, redox, and siderophore activity of a saccharide platform ferrichrome analogue
    • S. Dhungana et al. Iron chelation equilibria, redox, and siderophore activity of a saccharide platform ferrichrome analogue Inorg. Chem. 46 2007 8362 8371
    • (2007) Inorg. Chem. , vol.46 , pp. 8362-8371
    • Dhungana, S.1
  • 13
    • 70350766680 scopus 로고    scopus 로고
    • Iron metabolism: A promising target for antibacterial strategies
    • M. Ballouche et al. Iron metabolism: a promising target for antibacterial strategies Recent Pat. Antiinfect. Drug Discov. 4 2009 190 205
    • (2009) Recent Pat. Antiinfect. Drug Discov. , vol.4 , pp. 190-205
    • Ballouche, M.1
  • 14
    • 46149094595 scopus 로고    scopus 로고
    • New substrates for TonB-dependent transport: Do we only see the 'tip of the iceberg'?
    • K. Schauer et al. New substrates for TonB-dependent transport: do we only see the 'tip of the iceberg'? Trends Biochem. Sci. 33 2008 330 338
    • (2008) Trends Biochem. Sci. , vol.33 , pp. 330-338
    • Schauer, K.1
  • 15
    • 0034079929 scopus 로고    scopus 로고
    • Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA
    • A.D. Ferguson et al. Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA Protein Sci. 9 2000 956 963
    • (2000) Protein Sci. , vol.9 , pp. 956-963
    • Ferguson, A.D.1
  • 16
    • 59449092463 scopus 로고    scopus 로고
    • Sideromycins: Tools and antibiotics
    • V. Braun et al. Sideromycins: tools and antibiotics Biometals 22 2009 3 13
    • (2009) Biometals , vol.22 , pp. 3-13
    • Braun, V.1
  • 18
    • 34548724460 scopus 로고    scopus 로고
    • Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria
    • J. Lubelski et al. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria Microbiol. Mol. Biol. Rev. 71 2007 463 476
    • (2007) Microbiol. Mol. Biol. Rev. , vol.71 , pp. 463-476
    • Lubelski, J.1
  • 19
    • 0037853294 scopus 로고    scopus 로고
    • Tertiary structure of bacterial murein: The scaffold model
    • B.A. Dmitriev et al. Tertiary structure of bacterial murein: the scaffold model J. Bacteriol. 185 2003 3458 3468
    • (2003) J. Bacteriol. , vol.185 , pp. 3458-3468
    • Dmitriev, B.A.1
  • 20
    • 84875454942 scopus 로고    scopus 로고
    • Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus
    • T.A. Wencewicz et al. Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus Bioconjug. Chem. 24 2013 473 486
    • (2013) Bioconjug. Chem. , vol.24 , pp. 473-486
    • Wencewicz, T.A.1
  • 21
    • 84885382019 scopus 로고    scopus 로고
    • Curb challenges of the 'Trojan Horse' approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery
    • Y. Huang et al. Curb challenges of the 'Trojan Horse' approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery Adv. Drug Deliv. Rev. 65 2013 1299 1315
    • (2013) Adv. Drug Deliv. Rev. , vol.65 , pp. 1299-1315
    • Huang, Y.1
  • 22
    • 40049103479 scopus 로고    scopus 로고
    • Design and synthesis of a novel protected mixed ligand siderophore
    • P. Ding et al. Design and synthesis of a novel protected mixed ligand siderophore Tetrahedron Lett. 49 2008 2306 2310
    • (2008) Tetrahedron Lett. , vol.49 , pp. 2306-2310
    • Ding, P.1
  • 23
    • 84867393274 scopus 로고    scopus 로고
    • Syntheses of siderophore-drug conjugates using a convergent thiol-maleimide system
    • R.E. Juárez-Hernández et al. Syntheses of siderophore-drug conjugates using a convergent thiol-maleimide system ACS Med. Chem. Lett. 3 2012 799 803
    • (2012) ACS Med. Chem. Lett. , vol.3 , pp. 799-803
    • Juárez-Hernández, R.E.1
  • 24
    • 0029962175 scopus 로고    scopus 로고
    • Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore-vancomycin conjugates
    • M. Ghosh, and M.J. Miller Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore-vancomycin conjugates Bioorg. Med. Chem. 4 1996 43 48
    • (1996) Bioorg. Med. Chem. , vol.4 , pp. 43-48
    • Ghosh, M.1    Miller, M.J.2
  • 25
    • 84878035473 scopus 로고    scopus 로고
    • Biscatecholate-monohydroxamate mixed ligand siderophore- carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii
    • T.A. Wencewicz, and M.J. Miller Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii J. Med. Chem. 23 2013 4044 4052
    • (2013) J. Med. Chem. , vol.23 , pp. 4044-4052
    • Wencewicz, T.A.1    Miller, M.J.2
  • 26
    • 84862509089 scopus 로고    scopus 로고
    • Iron transport-mediated drug delivery: Practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore-aminopenicillin conjugates reveals selectively potent antipseudomonal activity
    • C. Ji et al. Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore- aminopenicillin conjugates reveals selectively potent antipseudomonal activity J. Am. Chem. Soc. 134 2012 9898 9901
    • (2012) J. Am. Chem. Soc. , vol.134 , pp. 9898-9901
    • Ji, C.1
  • 27
    • 80054124262 scopus 로고    scopus 로고
    • Medical applications of siderophores
    • B. Nagoba, and D. Vedpathak Medical applications of siderophores Eur. J. Gen. Med. 8 2011 229 235
    • (2011) Eur. J. Gen. Med. , vol.8 , pp. 229-235
    • Nagoba, B.1    Vedpathak, D.2
  • 28
    • 84945287688 scopus 로고    scopus 로고
    • Bacterial siderophore and their application: A review
    • S.S. Ali, and N.N. Vidhale Bacterial siderophore and their application: a review Int. J. Curr. Microbiol. App. Sci. 12 2013 303 312
    • (2013) Int. J. Curr. Microbiol. App. Sci. , vol.12 , pp. 303-312
    • Ali, S.S.1    Vidhale, N.N.2
  • 29
    • 0026728122 scopus 로고    scopus 로고
    • Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria
    • A. Brochu et al. Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria Antimicrob. Agents Chemother. 36 2001 2166 2175
    • (2001) Antimicrob. Agents Chemother. , vol.36 , pp. 2166-2175
    • Brochu, A.1
  • 30
    • 0034044581 scopus 로고    scopus 로고
    • Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents
    • J.M. Roosenberg et al. Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents Curr. Med. Chem. 7 2000 159 197
    • (2000) Curr. Med. Chem. , vol.7 , pp. 159-197
    • Roosenberg, J.M.1
  • 31
    • 0035352559 scopus 로고    scopus 로고
    • Siderophore-antibiotic conjugates used as trojan horses against Pseudomonas aeruginosa
    • H. Budzikiewicz Siderophore-antibiotic conjugates used as trojan horses against Pseudomonas aeruginosa Curr. Top. Med. Chem. 1 2001 73 82
    • (2001) Curr. Top. Med. Chem. , vol.1 , pp. 73-82
    • Budzikiewicz, H.1
  • 32
    • 10344230917 scopus 로고    scopus 로고
    • Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria
    • M.S. Diarra et al. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria Antimicrob. Agents Chemother. 40 1996 2610 2617
    • (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 2610-2617
    • Diarra, M.S.1
  • 33
    • 84887943889 scopus 로고    scopus 로고
    • Synthesis of carbohydrate-based artificial siderophores and their biological applications
    • A.P. Rauter, T. Lindhorst, Royal Society of Chemistry
    • M.M. Andrade, and A.P. Rauter Synthesis of carbohydrate-based artificial siderophores and their biological applications A.P. Rauter, T. Lindhorst, Carbohydrate Chemistry 2012 Royal Society of Chemistry 398 415
    • (2012) Carbohydrate Chemistry , pp. 398-415
    • Andrade, M.M.1    Rauter, A.P.2
  • 34
    • 0030453553 scopus 로고    scopus 로고
    • Iron transport-mediated drug delivery using mixed-ligand siderophore-β-lactam conjugates
    • A. Ghosh et al. Iron transport-mediated drug delivery using mixed-ligand siderophore-β-lactam conjugates Chem. Biol. 3 1996 1011 1019
    • (1996) Chem. Biol. , vol.3 , pp. 1011-1019
    • Ghosh, A.1
  • 35
    • 79960880056 scopus 로고    scopus 로고
    • Structure and biosynthesis of amychelin, an unusual mixed-ligand siderophore from Amycolatopsis sp. AA4
    • M.R. Seyedsayamdost et al. Structure and biosynthesis of amychelin, an unusual mixed-ligand siderophore from Amycolatopsis sp. AA4 J. Am. Chem. Soc. 133 2011 11434 11437
    • (2011) J. Am. Chem. Soc. , vol.133 , pp. 11434-11437
    • Seyedsayamdost, M.R.1
  • 36
    • 29844457587 scopus 로고    scopus 로고
    • The evolution of iron chelators for the treatment of iron overload disease and cancer
    • D.S. Kalinowski, and D.R. Richardson The evolution of iron chelators for the treatment of iron overload disease and cancer Pharmacol. Rev. 57 2005 547 583
    • (2005) Pharmacol. Rev. , vol.57 , pp. 547-583
    • Kalinowski, D.S.1    Richardson, D.R.2
  • 37
    • 77956126203 scopus 로고    scopus 로고
    • Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation
    • Y. Liu et al. Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation Antimicrob. Agents Chemother. 54 2010 3960 3963
    • (2010) Antimicrob. Agents Chemother. , vol.54 , pp. 3960-3963
    • Liu, Y.1
  • 38
    • 2142824217 scopus 로고    scopus 로고
    • Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously
    • C. Llanes et al. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously Antimicrob. Agents Chemother. 48 2004 1797 1802
    • (2004) Antimicrob. Agents Chemother. , vol.48 , pp. 1797-1802
    • Llanes, C.1
  • 39
    • 0034426126 scopus 로고    scopus 로고
    • Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
    • N. Masuda et al. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 44 2000 3322 3327
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 3322-3327
    • Masuda, N.1
  • 40
    • 0031750326 scopus 로고    scopus 로고
    • The synthesis and antibacterial activity of two pyoverdin-ampicillin conjugates, entering Pseudomonas aeruginosa via the pyoverdin-mediated iron uptake pathway
    • O. Kinzel et al. The synthesis and antibacterial activity of two pyoverdin-ampicillin conjugates, entering Pseudomonas aeruginosa via the pyoverdin-mediated iron uptake pathway J. Antibiot. (Tokyo) 51 1998 499 507
    • (1998) J. Antibiot. (Tokyo) , vol.51 , pp. 499-507
    • Kinzel, O.1
  • 41
    • 84877655609 scopus 로고    scopus 로고
    • Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics
    • S.J. Milner et al. Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics Org. Biomol. Chem. 11 2013 3461 3468
    • (2013) Org. Biomol. Chem. , vol.11 , pp. 3461-3468
    • Milner, S.J.1
  • 42
    • 24944457520 scopus 로고    scopus 로고
    • Iron chelation therapy
    • C.M. Hershko et al. Iron chelation therapy Curr. Hematol. Rep. 4 2005 110 116
    • (2005) Curr. Hematol. Rep. , vol.4 , pp. 110-116
    • Hershko, C.M.1
  • 43
    • 0041808770 scopus 로고    scopus 로고
    • Mechanism of iron toxicity
    • A. Pietrangelo Mechanism of iron toxicity Adv. Exp. Med. Biol. 509 2002 19 43
    • (2002) Adv. Exp. Med. Biol. , vol.509 , pp. 19-43
    • Pietrangelo, A.1
  • 44
    • 79952488109 scopus 로고    scopus 로고
    • Application of magnetic particles in pharmaceutical sciences
    • M.P. Marszałł Application of magnetic particles in pharmaceutical sciences Pharm. Res. 28 2011 480 483
    • (2011) Pharm. Res. , vol.28 , pp. 480-483
    • Marszałł, M.P.1
  • 45
    • 67650672138 scopus 로고    scopus 로고
    • Biomedical applications of distally controlled magnetic nanoparticles
    • J.L. Corchero, and A. Villaverde Biomedical applications of distally controlled magnetic nanoparticles Trends Biotechnol. 27 2009 468 476
    • (2009) Trends Biotechnol. , vol.27 , pp. 468-476
    • Corchero, J.L.1    Villaverde, A.2
  • 46
    • 79952485717 scopus 로고    scopus 로고
    • Biomagnetic methods: Technologies applied to pharmaceutical research
    • A. Luciana et al. Biomagnetic methods: technologies applied to pharmaceutical research Pharm. Res. 28 2011 438 455
    • (2011) Pharm. Res. , vol.28 , pp. 438-455
    • Luciana, A.1
  • 47
    • 84964884284 scopus 로고    scopus 로고
    • The development of magnetic drug delivery and disposition
    • A.A. Hashim, InTech
    • M.P. Marszałł The development of magnetic drug delivery and disposition A.A. Hashim, The Delivery of Nanoparticles 2012 InTech 95 110
    • (2012) The Delivery of Nanoparticles , pp. 95-110
    • Marszałł, M.P.1
  • 48
    • 84862658644 scopus 로고    scopus 로고
    • Magnetic nanoparticles in magnetic resonance imaging and diagnostics
    • Ch. Rumenapp et al. Magnetic nanoparticles in magnetic resonance imaging and diagnostics Pharm. Res. 29 2012 1165 1179
    • (2012) Pharm. Res. , vol.29 , pp. 1165-1179
    • Rumenapp, Ch.1
  • 49
    • 61349139614 scopus 로고    scopus 로고
    • Drug delivery and nanoparticles: Applications and hazards
    • W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles: applications and hazards Int. J. Nanomedicine 3 2008 133 149
    • (2008) Int. J. Nanomedicine , vol.3 , pp. 133-149
    • De Jong, W.H.1    Borm, P.J.2
  • 50
    • 34548507968 scopus 로고    scopus 로고
    • Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae
    • A. Pramanik et al. Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae Int. J. Med. Microbiol. 297 2007 459 469
    • (2007) Int. J. Med. Microbiol. , vol.297 , pp. 459-469
    • Pramanik, A.1
  • 52
    • 42449155111 scopus 로고    scopus 로고
    • The evolution of gene collectives: How natural selection drives chemical innovation
    • M.A. Fischbach et al. The evolution of gene collectives: how natural selection drives chemical innovation Proc. Natl. Acad. Sci. U.S.A. 105 2008 4601 4608
    • (2008) Proc. Natl. Acad. Sci. U.S.A. , vol.105 , pp. 4601-4608
    • Fischbach, M.A.1
  • 53
    • 0037971906 scopus 로고    scopus 로고
    • Solid-phase synthesis of methyl carboxymycobactin T 7 and analogues as potential antimycobacterial agents
    • A.R. Poreddy et al. Solid-phase synthesis of methyl carboxymycobactin T 7 and analogues as potential antimycobacterial agents Bioorg. Med. Chem. Lett. 13 2003 2553 2556
    • (2003) Bioorg. Med. Chem. Lett. , vol.13 , pp. 2553-2556
    • Poreddy, A.R.1
  • 54
    • 0032574771 scopus 로고    scopus 로고
    • Lipophilic siderophores of mycobacterium tuberculosis prevent cardiac reperfusion injury
    • L.D. Horwitz et al. Lipophilic siderophores of mycobacterium tuberculosis prevent cardiac reperfusion injury Proc. Natl. Acad. Sci. U.S.A. 95 1998 5263 5268
    • (1998) Proc. Natl. Acad. Sci. U.S.A. , vol.95 , pp. 5263-5268
    • Horwitz, L.D.1
  • 55
    • 27144560152 scopus 로고    scopus 로고
    • Combined therapy with deferiprone and desferrioxamine in thalassemia major
    • R. Origa et al. Combined therapy with deferiprone and desferrioxamine in thalassemia major Haematologica 90 2005 1309 1314
    • (2005) Haematologica , vol.90 , pp. 1309-1314
    • Origa, R.1
  • 56
    • 0031001278 scopus 로고    scopus 로고
    • Iron-chelating therapy and the treatment of thalassemia
    • N.F. Olivieri, and G.M. Brittenham Iron-chelating therapy and the treatment of thalassemia Blood 89 1997 739 761
    • (1997) Blood , vol.89 , pp. 739-761
    • Olivieri, N.F.1    Brittenham, G.M.2
  • 57
    • 84864943245 scopus 로고    scopus 로고
    • Desferrioxamine attenuates pancreatic injury after major hepatectomy under vascular control of the liver: Experimental study in pigs
    • P. Varsos et al. Desferrioxamine attenuates pancreatic injury after major hepatectomy under vascular control of the liver: experimental study in pigs HPB Surg. 2012 2012 714672
    • (2012) HPB Surg. , vol.2012 , pp. 714672
    • Varsos, P.1
  • 58
    • 0020774896 scopus 로고
    • Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis
    • L. Kremp et al. Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis Arch. Fr. Pediatr. 40 1983 475 477
    • (1983) Arch. Fr. Pediatr. , vol.40 , pp. 475-477
    • Kremp, L.1
  • 59
    • 0344392914 scopus 로고    scopus 로고
    • Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy
    • T. Yang et al. Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy J. Lab. Clin. Med. 142 2003 332 340
    • (2003) J. Lab. Clin. Med. , vol.142 , pp. 332-340
    • Yang, T.1
  • 60
    • 0037323129 scopus 로고    scopus 로고
    • Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy
    • C.A. Obejero-Paz et al. Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy J. Lab. Clin. Med. 141 2003 121 130
    • (2003) J. Lab. Clin. Med. , vol.141 , pp. 121-130
    • Obejero-Paz, C.A.1
  • 61
    • 0042575616 scopus 로고    scopus 로고
    • The protective and therapeutic effects of zinc chloride and desferrioxamine on skin exposed to nitrogen mustard
    • T. Karayilanoǧlu et al. The protective and therapeutic effects of zinc chloride and desferrioxamine on skin exposed to nitrogen mustard Mil. Med. 168 2003 614 617
    • (2003) Mil. Med. , vol.168 , pp. 614-617
    • Karayilanoǧlu, T.1
  • 62
    • 0037297556 scopus 로고    scopus 로고
    • Preventative effect of deferoxamine on degenerative changes in the optic nerve in experimental retrobulbar haematoma
    • A. Pelit et al. Preventative effect of deferoxamine on degenerative changes in the optic nerve in experimental retrobulbar haematoma Clin. Experiment. Ophthalmol. 31 2003 66 72
    • (2003) Clin. Experiment. Ophthalmol. , vol.31 , pp. 66-72
    • Pelit, A.1
  • 63
    • 0037232582 scopus 로고    scopus 로고
    • Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model
    • V.S. Chekanov et al. Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model Ann. Thorac. Surg. 75 2003 184 189
    • (2003) Ann. Thorac. Surg. , vol.75 , pp. 184-189
    • Chekanov, V.S.1
  • 64
    • 0027194737 scopus 로고
    • Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle
    • G.A. Fantini, and T. Yoshioka Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle Am. J. Physiol. 264 1993 1953 1959
    • (1993) Am. J. Physiol. , vol.264 , pp. 1953-1959
    • Fantini, G.A.1    Yoshioka, T.2
  • 65
    • 7244239197 scopus 로고    scopus 로고
    • Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: A link between iron metabolism and proliferation
    • N.T. Le, and D.R. Richardson Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation Blood 104 2004 2967 2975
    • (2004) Blood , vol.104 , pp. 2967-2975
    • Le, N.T.1    Richardson, D.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.